SONNET BIOTHERAPEUTICS HOLDI (SONN)

US83548R3030 - Common Stock

1.79  +0.02 (+1.13%)

Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to SONN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 23.46. This target is 1210.61% above the current price.
SONN was analyzed by 10 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about SONN.
In the previous month the buy percentage consensus was at a similar level.
SONN was analyzed by 10 analysts. More opinions would make the average more meaningful.

Related screens

Price Target & Forecast

Price Low Median Mean High 1.797.0720.9123.4646.20 - 294.97% 1,068.16% 1,210.61% 2,481.01%

Related screens

Up and Down Grades
Date Firm Action Rating
2024-02-15 Chardan Capital Maintains Buy -> Buy
2023-11-27 Ladenburg Thalmann Initiate Buy
2023-08-16 Chardan Capital Maintains Buy -> Buy
2023-06-26 EF Hutton Reiterate Buy -> Buy
2023-05-11 Chardan Capital Maintains Buy -> Buy
2023-04-19 EF Hutton Reiterate Buy
2023-04-19 Chardan Capital Maintains Buy
2023-02-15 EF Hutton Reiterate Buy
2022-12-19 EF Hutton Initiate Buy
2022-09-22 Chardan Capital Maintains Buy
2022-08-16 Chardan Capital Maintains Buy
2022-02-09 BTIG Maintains Buy
2021-12-20 Chardan Capital Maintains Buy
2021-12-16 HC Wainwright & Co. Initiate Buy
2021-09-15 BTIG Initiate Buy